I recently attended an intake and medication management appointment at Laureate Psychiatry with the expectation of continuing an existing, physician-managed treatment plan that had been initiated out of state. I came prepared, having spent considerable time documenting my full medical and psychiatric history to ensure continuity of care.
During my visit, I was informed that my prescribed medication, which I had been taking consistently under medical supervision, would not be continued. The reason given was not based on an individualized medical assessment, contraindication, or state regulation—but rather described as “company policy,” specifically related to prior cannabis use, which I had already disclosed and had plans to discontinue as part of my treatment.
What is most concerning is not simply the refusal itself, but the lack of a medically appropriate transition plan. Abrupt discontinuation of a benzodiazepine, even after relatively short-term use, can carry risks. These… concerns were raised during the appointment but were not meaningfully addressed. Instead, the conversation repeatedly defaulted back to policy rather than patient-specific clinical judgment.
Immediately following this appointment, I sought care from my primary care physician the same day. After reviewing my situation, he determined that continuing the medication temporarily was the safer course of action while arranging appropriate psychiatric follow-up, and a prescription was issued accordingly.
This contrast is important. It demonstrates that there was, in fact, a medically reasonable path forward that prioritized patient safety and continuity of care—something I did not experience during my visit at Laureate.
Additionally, the structure of the visit itself was confusing. A significant amount of time was spent on in-depth personal and psychological questioning, which closely resembled therapy or evaluation, yet I was later told this was strictly a medication management visit and that therapy would be separate. This lack of clarity added to an already frustrating experience.
I am not opposed to clinical caution, alternative treatment approaches, or even differing medical opinions. However, I do expect that decisions—especially those involving the discontinuation of an active medication—are communicated clearly, justified medically, and accompanied by a safe plan.
Patients seeking care are not just cases to be filtered through policy. They are individuals who rely on providers to balance clinical judgment with safety and continuity. Unfortunately, that balance was not reflected in my experience.
For those considering this facility, I would strongly encourage asking detailed questions about prescribing policies and transition protocols in advance, particularly if you are transferring care from another provider.
Read More 
